HIGHLIGHTS
- who: Haiyang Du from the Medical University, China have published the Article: The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimeru2019s disease, in the Journal: (JOURNAL)
- what: Increasing evidence suggests that anti-diabetes medicine, GLP-1R agonists, have multiple neuroprotective mechanisms frontiersin.org 10.3389/fendo.2022.1033479 in AD models, such as anti-inflammation, anti-oxidative stress, reducing Ab aggregation/deposition and tau protein hyperphosphorylation, reducing neuronal apoptosis and neurotoxicity, increasing cell proliferation and neurogenesis, increasing synaptic plasticity, and other beneficial effects.
- how: Data showed that GLP . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.